ArticleCell systems2024

To modulate or to skip: De-escalating PARP inhibitor maintenance therapy in ovarian cancer using adaptive therapy.

Maximilian A R Strobl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.